Camlin Fine Sciences Q2 FY27: revenue up 6.9% to ₹492 Cr, net loss ₹30 Cr
Results · Finvezto · 3 Nov 2026 · Camlin Fine Sciences (CAMLINFINE)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 492 | - | +6.9% |
| Operating profit | 2 | - | -93.3% |
| Net profit | -30 | - | - |
| Operating margin | 0.4% | - | -6.7 pp |
| Net margin | -6.0% | - | - |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- The Board approved a rights issue of around INR 250 crores to augment working capital and resolve persistent liquidity constraints. Earnings call
- Aroma segment revenue declined from INR 774 million to INR 472 million due to plant underutilization and the transition to ethyl vanillin. Earnings call
- Overall EBITDA margin dropped to 2.5% in Q2 FY27, impacted by high input costs, doubled freight expenses, and channel financing charges. Earnings call
What to watch
- Management on q4 fy27 financial performance: The turnaround, we expect the top line to be INR600 crores and the EBITDA to be INR60 crores plus in Q4.
- Management on vanillin volume target: We are looking at that we can be able to with an effective distributor management and identifying strong distributors, we can push at least 1,000 metric tons per quarter at a reasonable price of $12-odd.
Links
Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.